Clinical Applications of Stem Cells. Co-organised with The Singapore Bioimaging Consortium, SBIC.

The Singapore Bioimaging Consortium and Select Biosciences South East Asia present the Clinical Applications of Stem Cells. Taking place on the 26-27 February 2015, at Academia, a state-of-the-art conference facility housed in the campus of Singapore General Hospital, Singapore.

Having successfully run an allied event for the last two years in Palm Desert, California, USA, we look forward
to bringing the subject matter to Singapore.

We are pleased to welcome Dr. Larry Stanton, Senior Group Leader/Associate Director, Stem Cell and
Regenerative Biology, Genome Institute of Singapore as our Conference Chairman.

The event will bring together researchers and clinicians focusing on translating basic discoveries in the stem
cells field into applications for regenerative medicine and cellular therapy.

We will also be looking specifically into how the global regulatory agencies view the translational efforts. The
meeting will run over two full days, with presentations from clinicians, regulatory bodies, academia and
industry, leading into panel discussions each afternoon to cover the points raised during the earlier sessions.

Attending this conference will provide you with a detailed overview of the current research, clinical practices
and regulatory requirements in this rapidly developing field.

Keynote Speakers
Larry Stanton - Senior Group Leader/Associate Director, Stem Cell and Regenerative Biology, Genome Institute of Singapore
Edward Lanphier - President & Chief Executive Officer, Sangamo BioSciences Inc

Agenda Topics
• Adipose-derived Stem Cells
• Adult Stem Cells for Cellular Therapy
• Clinical Translational Applications with Pluripotent Stem Cells
• Cosmetic Surgery and Associated Applications
• Current State of the Science
• Dental Applications
• Disease Classes Addressed and Current Status of Ongoing Clinical Trials
• Orthopaedic Applications
• Regulatory Landscape and Ethical Considerations
• Research vs. Clinical Challenges in Stem Cell Translation
• The Path to Commercialization
• Umbilical Cord Blood-derived Stem Cells
• Veterinary Applications of Stem Cells
• Wound and Burn Healing

Media Contact:
Paul Raggett, CEO
Select Biosciences South East Asia Pte. Ltd.
16 Raffles Quay, #33-03 Hong Leong Building,
Singapore 048581
Tel: +65 9186 3246
Email: [email protected]

From 26 Feb 2015
Until 27 Feb 2015
News topics: